Polaryx Therapeutics, Inc. Common Stock
Status: Publicly traded
Direct answer
Polaryx Therapeutics, Inc. Common Stock is publicly traded on NASDAQ under the ticker PLYX.
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound...
Can you invest in Polaryx Therapeutics, Inc. Common Stock?
Yes. Polaryx Therapeutics, Inc. Common Stock trades publicly on NASDAQ as PLYX.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Polaryx Therapeutics, Inc. Common Stock
Detailed equity research is provided by MarketSnap.